Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 4,546 shares at $25.85 ($118K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($118k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 2,273 | $59K | 50.0% |
| 2 | $25.85 | 2,273 | $59K | 50.0% |
| Total | $25.85 avg | 4,546 | $118K | 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |